For topical use only. Apply a small amount to the affected area and gently rub it in. Wash hands thoroughly before and after application, unless hands are the treated area. Avoid contact with eyes, mouth, and other mucous membranes.

Betamethasone Dipropionate is a potent corticosteroid that acts by inducing phospholipase A2 inhibitory proteins (lipocortins), thereby controlling the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes. Fusidic Acid is an antibiotic that inhibits bacterial protein synthesis, primarily by interfering with the translocation step of elongation factor G during protein synthesis. This leads to the inhibition of growth and multiplication of susceptible bacteria.

• •Hypersensitivity to Betamethasone Dipropionate, Fusidic Acid, or any other component of the formulation
• •Primary bacterial skin infections without accompanying inflammatory conditions (e.g., impetigo)
• •Primary fungal or viral skin infections (e.g., herpes simplex, varicella)
• •Perioral dermatitis
• •Rosacea
• •Acne vulgaris
• •Ulcerative conditions
• •Tuberculosis of the skin
• •Vaccination reactions

Store below 30°C. Protect from light and moisture. Do not freeze. Keep out of reach of children.

Acute overdose is unlikely due to the nature of the topical application. Prolonged or excessive use may lead to local adverse effects such as skin atrophy, striae, or systemic effects of corticosteroids (e.g., Cushing's syndrome, adrenal suppression) if significant absorption occurs. Management involves gradual withdrawal of the drug.

Pregnancy: Use with caution during pregnancy only if the potential benefit justifies the potential risk to the fetus. Avoid large areas, prolonged use, or occlusive dressings. Lactation: It is not known whether topically administered corticosteroids are absorbed systemically in sufficient amounts to produce detectable quantities in breast milk. Use with caution during lactation; do not apply to the breast area.